Table 4-23Summary of results

STUDYPancreatic enzyme preparationFaecal Fat: g/day% mean reductionP value (compared to basal score)
DELHAYE173Pancrease HL10.68 ± 0.66-NS
GOUEROU170Pancrease13.9 ± 12.9640NS*
DELHAYE173Pancrease HL + omeprazole9.52 ± 0.71-0.03
VECHT176Pancrease, 10,000 + omeprazole17.9 ± 6.551<0.01
Pancrease, 20,000 + omeprazole18.3 ± 4.750<0.01
DELHAYECreon 310.26 ± 0.61-NS
Creon 3 + omeprazole9.14 ± 0.56-0.03
LANKISCHPankreon 70033.544NS*
Pankreon 700 + cimetidine23.660NS*
GOUEROU170Eurobiol12.32 ± 9.4846NS

These studies included patients without steatorrhoea and this may have affected the result 165,167

NS = not significant

From: 4, Alcohol-related Pancreatitis

Cover of Alcohol Use Disorders
Alcohol Use Disorders: Diagnosis and Clinical Management of Alcohol-Related Physical Complications [Internet].
NICE Clinical Guidelines, No. 100.
National Clinical Guideline Centre (UK).
Copyright © 2010, National Clinical Guidelines Centre.

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.